CRH Medical Corporation Common Shares of Beneficial Interest (CRHM): Price and Financial Metrics

CRH Medical Corporation Common Shares of Beneficial Interest (CRHM)

Today's Latest Price: $2.24 USD

0.02 (-0.88%)

Updated Jan 22 8:00pm

Add CRHM to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 77 in Medical - Services

See all "A" rated Strong Buy stocks

CRHM Stock Summary

  • CRHM's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.64 -- higher than just 5.92% of US-listed equities with positive expected earnings growth.
  • Of note is the ratio of CRH Medical Corp's sales and general administrative expense to its total operating expenses; 88.08% of US stocks have a lower such ratio.
  • The ratio of debt to operating expenses for CRH Medical Corp is higher than it is for about 90.39% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to CRH Medical Corp are MSGN, CHCI, MTA, CG, and GRIL.
  • CRHM's SEC filings can be seen here. And to visit CRH Medical Corp's official web site, go to

CRHM Stock Price Chart Interactive Chart >

Price chart for CRHM

CRHM Price/Volume Stats

Current price $2.24 52-week high $4.43
Prev. close $2.26 52-week low $0.86
Day low $2.21 Volume 31,300
Day high $2.26 Avg. volume 67,443
50-day MA $2.53 Dividend yield N/A
200-day MA $2.29 Market Cap 160.52M

CRH Medical Corporation Common Shares of Beneficial Interest (CRHM) Company Bio

CRH Medical Corporation, a medical company, provides products and services to physicians for the treatment of gastrointestinal diseases in the United States. The company was founded in 2000 and is based in Vancouver, Canada.

CRHM Latest News Stream

Event/Time News Detail
Loading, please wait...

CRHM Latest Social Stream

Loading social stream, please wait...

View Full CRHM Social Stream

Latest CRHM News From Around the Web

Below are the latest news stories about CRH Medical Corp that investors may wish to consider to help them evaluate CRHM as an investment opportunity.

If You Own CRH Medical Corp (CRHM) Stock, Should You Sell It Now?

Greystone Capital recently released its Q4 2020 Investor Letter, a copy of which you can download here. Greystone is a privately held investment company. The investment firm seeks to simplify and add value by identifying opportunities in good and bad markets. During the fourth quarter of 2020, returns for separate accounts managed by Greystone Capital […]

Yahoo | January 20, 2021

What Kind Of Shareholders Own CRH Medical Corporation (TSE:CRH)?

If you want to know who really controls CRH Medical Corporation ( TSE:CRH ), then you'll have to look at the makeup of...

Yahoo | January 11, 2021

New Resource for Survivors from NCCN Helps Guide Life After Cancer Diagnosis and Treatment

New NCCN Guidelines for Patients: Survivorship series provides expert advice to help cancer survivors sustain better health while monitoring for any long-term side effects or recurrences.SURVIVOR TV show winner and cancer survivor, Ethan Zohn shares what cancer survivorship means to him.

Yahoo | January 5, 2021

CRH Medical - Don't Be Seduced by the Free Cash Flow

This is a case where just looking at cash flow can result in an incorrect assessment

Yahoo | December 28, 2020

CRH Medical Corporation Announces Customer Update

CRH Medical Corporation ("CRH", or the "Company") (TSX: CRH) (NYSE MKT: CRHM) announces that it has received notice today that its largest customer, United Digestive ("UD"), does not intend to renew its professional services agreements pursuant to which CRH provides anesthesia services to 12 of UD's surgery centers in the Greater Atlanta Georgia market. UD represents a significant portion of CRH's revenue, and is expected to represent approximately 20% of adjusted operating shareholder EBITDA ("EBITDA") in 2021. The current professional services agreements are scheduled to expire on October 31, 2021, meaning that the non-renewal will become effective sometime thereafter, such that the effect on CRH's financial results will be seen beginning in 2022.

Yahoo | December 23, 2020

Read More 'CRHM' Stories Here

CRHM Price Returns

1-mo N/A
3-mo 4.67%
6-mo -3.03%
1-year -43.58%
3-year -27.74%
5-year -13.85%
YTD -3.86%
2020 -32.85%
2019 13.77%
2018 15.09%
2017 -49.52%
2016 77.97%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.722 seconds.